Phase II trial of docetaxel for cholangiocarcinoma.
Saved in:
| Title: | Phase II trial of docetaxel for cholangiocarcinoma. |
|---|---|
| Authors: | Pazdur R; University of Texas M.D. Anderson Cancer Center, Houston 77030, USA., Royce ME, Rodriguez GI, Rinaldi DA, Patt YZ, Hoff PM, Burris HA |
| Source: | American journal of clinical oncology [Am J Clin Oncol] 1999 Feb; Vol. 22 (1), pp. 78-81. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Print ISSN: 0277-3732 (Print) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 10025387 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II trial of docetaxel for cholangiocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pazdur+R%22">Pazdur R</searchLink>; University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.<br /><searchLink fieldCode="AU" term="%22Royce+ME%22">Royce ME</searchLink><br /><searchLink fieldCode="AU" term="%22Rodriguez+GI%22">Rodriguez GI</searchLink><br /><searchLink fieldCode="AU" term="%22Rinaldi+DA%22">Rinaldi DA</searchLink><br /><searchLink fieldCode="AU" term="%22Patt+YZ%22">Patt YZ</searchLink><br /><searchLink fieldCode="AU" term="%22Hoff+PM%22">Hoff PM</searchLink><br /><searchLink fieldCode="AU" term="%22Burris+HA%22">Burris HA</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228207754%22">American journal of clinical oncology</searchLink> [Am J Clin Oncol] 1999 Feb; Vol. 22 (1), pp. 78-81. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8207754 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0277-3732 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202773732%22">02773732 </searchLink><i>NLM ISO Abbreviation: </i>Am J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=10025387 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/00000421-199902000-00019 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 78 Titles: – TitleFull: Phase II trial of docetaxel for cholangiocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pazdur R – PersonEntity: Name: NameFull: Royce ME – PersonEntity: Name: NameFull: Rodriguez GI – PersonEntity: Name: NameFull: Rinaldi DA – PersonEntity: Name: NameFull: Patt YZ – PersonEntity: Name: NameFull: Hoff PM – PersonEntity: Name: NameFull: Burris HA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 1999 Feb Type: published Y: 1999 Identifiers: – Type: issn-print Value: 0277-3732 Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: American journal of clinical oncology Type: main |
| ResultId | 1 |
